BENSULFOID Drug Patent Profile
✉ Email this page to a colleague
When do Bensulfoid patents expire, and when can generic versions of Bensulfoid launch?
Bensulfoid is a drug marketed by Poythress and is included in one NDA.
The generic ingredient in BENSULFOID is sulfur. There are two drug master file entries for this compound. Additional details are available on the sulfur profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENSULFOID?
- What are the global sales for BENSULFOID?
- What is Average Wholesale Price for BENSULFOID?
Summary for BENSULFOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 33 |
| DailyMed Link: | BENSULFOID at DailyMed |
US Patents and Regulatory Information for BENSULFOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poythress | BENSULFOID | sulfur | POWDER;TOPICAL | 002918-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
